Robert Dean Stebbins
Medical and research professional Robert Dean Stebbins, MD, treated 1,600 patients annually, consulted with international corporate executives, and managed a certified laboratory in his hematology, oncology, and internal medicine private practice in Palo Alto, California. Specializing in breast cancer and leukemia treatment, he employed a professional staff of six while maintaining the practice for 20 years. Dr. Robert Dean Stebbins, also taught at Stanford University School of Medicine where he advanced from Clinical Instructor to Clinical Professor of Medicine.
Following his graduation from the University of Southern California (USC) School of Medicine, Robert Dean Stebbins, MD, completed an internship and residency at Los Angeles County-USC Medical Center. He served as a staff physician in internal medicine at this facility and subsequently became a Research Associate in hematology in the Department of Pathology at Columbia University College of Physicians and Surgeons. While completing a fellowship in hematology at New York University School of Medicine, where he later accepted a post as Instructor in Medicine, Dr. Stebbins, acted as an Assistant Attending Physician at Harlem Hospital Center in New York. Prior to fulfilling a fellowship in oncology at Yale School of Medicine, he joined Goldwater Memorial Hospital in New York as a Visiting Physician and Consulting Hematologist.
In research positions, Robert D. Stebbins, MD, has compiled and analyzed data for a National Institutes of Health study on infants with extremely low birth weights and created comprehensive research protocolswhile directing clinical stent implantations for CardioSynopsis, Inc.. A prolific writer, he has contributed to numerous professional publications such as “Serum Tumor Markers” in Immunoassay: Laboratory Analysis and Clinical Applications. A teacher at medical schools for more than two decades, Robert Dean Stebbins, MD, earned the prestigious Russell V. Lee Clinical Teaching Award.
Achieving diplomate status with the American Board of Internal Medicine and earning certification from the Subspecialty Boards in Medical Oncology and Hematology.